Ming-hong H. Chang

Taitung, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

Clinical and genetic characterization of hereditary spastic paraplegia type 4 in a Taiwanese cohort.

Clinical and genetic characterization of hereditary spastic paraplegia type 4 in a Taiwanese cohort.

Journal: Parkinsonism & related disorders

Published: May 25, 2026

Association of sodium-glucose cotransporter 2 inhibitors with the risk of incident anxiety and insomnia: a retrospective cohort study using the TriNetX database.

Association of sodium-glucose cotransporter 2 inhibitors with the risk of incident anxiety and insomnia: a retrospective cohort study using the TriNetX database.

Journal: Diabetes & metabolic syndrome

Published: September 04, 2025

The added value of anosmic subtype on motor subtype in Parkinson's disease: a pilot study.

The added value of anosmic subtype on motor subtype in Parkinson's disease: a pilot study.

Journal: Scientific reports

Published: November 02, 2024

What does it mean when the pleasant smells come and go? Correlation between UPSIT odor identification status and fluctuation of non-motor symptoms in Parkinson's disease.

What does it mean when the pleasant smells come and go? Correlation between UPSIT odor identification status and fluctuation of non-motor symptoms in Parkinson's disease.

Journal: Acta neurologica Belgica

Published: July 04, 2024

Association of sodium-glucose cotransporter 2 inhibitors with risk of incident dementia and all-cause mortality in older patients with type 2 diabetes: A retrospective cohort study using the TriNetX US collaborative networks.

Association of sodium-glucose cotransporter 2 inhibitors with risk of incident dementia and all-cause mortality in older patients with type 2 diabetes: A retrospective cohort study using the TriNetX US collaborative networks.

Journal: Diabetes, obesity & metabolism

Published: June 12, 2024

Glycemic variability's impact on painful diabetic peripheral neuropathy in type 2 diabetes patients.

Glycemic variability's impact on painful diabetic peripheral neuropathy in type 2 diabetes patients.

Journal: Scientific reports

Published: May 09, 2024

Diabetic peripheral neuropathy: age-stratified glycemic control.

Diabetic peripheral neuropathy: age-stratified glycemic control.

Journal: Frontiers in endocrinology

Published: January 28, 2024

The greatest loss of unpleasant smells may be related to the risk of more severe PD symptoms.

The greatest loss of unpleasant smells may be related to the risk of more severe PD symptoms.

Journal: Frontiers in neurology

Published: December 29, 2023

Impact of olfactory function on the trajectory of cognition, motor function, and quality of life in Parkinson's disease.

Impact of olfactory function on the trajectory of cognition, motor function, and quality of life in Parkinson's disease.

Journal: Frontiers in aging neuroscience

Published: October 29, 2023

UPSIT subitems may predict motor progression in Parkinson's disease.

UPSIT subitems may predict motor progression in Parkinson's disease.

Journal: Frontiers in neurology

Published: July 23, 2023

Sequential change in olfaction and (non) motor symptoms: the difference between anosmia and non-anosmia in Parkinson's disease.

Sequential change in olfaction and (non) motor symptoms: the difference between anosmia and non-anosmia in Parkinson's disease.

Journal: Frontiers in aging neuroscience

Published: April 28, 2023

The association between hyperlipidemia, lipid-lowering drugs and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus.

The association between hyperlipidemia, lipid-lowering drugs and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus.

Journal: PloS one

Published: August 28, 2022

Showing 1-12 of 58

Last Updated: 09/26/2026